CXCR4 together with its cognate ligand CXCL12 (stromal cell-derived factor-1/SDF-1) is widely expressed in various different cancers, and it is somewhat surprising that its expression did not correlate with patient survival. This evidence concerns the gene CXCL12 and cancer.